Astrana Health Stock EBITDA
| ASTH Stock | 43.25 0.39 0.91% |
Astrana Health fundamentals help investors to digest information that contributes to Astrana Health's financial success or failures. It also enables traders to predict the movement of Astrana Stock. The fundamental analysis module provides a way to measure Astrana Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Astrana Health stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 123.7 M | 129.9 M |
Astrana | EBITDA |
Astrana Health Company EBITDA Analysis
Astrana Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Astrana Health EBITDA | 123.69 M |
Most of Astrana Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astrana Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Astrana EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Astrana Health is extremely important. It helps to project a fair market value of Astrana Stock properly, considering its historical fundamentals such as EBITDA. Since Astrana Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Astrana Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Astrana Health's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Astrana Ebitda
Ebitda |
|
According to the company disclosure, Astrana Health reported earnings before interest,tax, depreciation and amortization of 123.69 M. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is notably lower than that of the firm.
Astrana EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.Astrana Health is currently under evaluation in ebitda category among its peers.
Astrana Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Astrana Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Astrana Health's managers, analysts, and investors.Environmental | Governance | Social |
Astrana Health Institutional Holders
Institutional Holdings refers to the ownership stake in Astrana Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Astrana Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Astrana Health's value.| Shares | Northern Trust Corp | 2024-09-30 | 424.1 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 342.6 K | Fort Washington Investment Advisors Inc | 2024-09-30 | 299.8 K | Bank Of New York Mellon Corp | 2024-09-30 | 268.7 K | Goldman Sachs Group Inc | 2024-09-30 | 258.9 K | Royal Bank Of Canada | 2024-09-30 | 254.6 K | Bellevue Group Ag | 2024-09-30 | 254.2 K | Amvescap Plc. | 2024-09-30 | 241.8 K | Atria Wealth Solutions, Inc. | 2024-09-30 | 237.4 K | Blackrock Inc | 2024-06-30 | 6.4 M | Vanguard Group Inc | 2024-09-30 | 4.7 M |
Astrana Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0449 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 2.1 B | ||||
| Shares Outstanding | 45.65 M | ||||
| Shares Owned By Insiders | 23.69 % | ||||
| Shares Owned By Institutions | 46.00 % | ||||
| Number Of Shares Shorted | 1.56 M | ||||
| Price To Book | 2.80 X | ||||
| Price To Sales | 1.15 X | ||||
| Revenue | 1.39 B | ||||
| Gross Profit | 199.48 M | ||||
| EBITDA | 123.69 M | ||||
| Net Income | 57.85 M | ||||
| Total Debt | 321.01 M | ||||
| Book Value Per Share | 14.75 X | ||||
| Cash Flow From Operations | 68.23 M | ||||
| Short Ratio | 5.13 X | ||||
| Earnings Per Share | 1.30 X | ||||
| Target Price | 67.11 | ||||
| Number Of Employees | 1.8 K | ||||
| Beta | 1.24 | ||||
| Market Capitalization | 1.97 B | ||||
| Total Asset | 933.36 M | ||||
| Retained Earnings | 243.13 M | ||||
| Working Capital | 242.83 M | ||||
| Net Asset | 933.36 M |
About Astrana Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Astrana Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Astrana Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Astrana Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:Check out Astrana Health Piotroski F Score and Astrana Health Altman Z Score analysis. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.